Penn Muluhngwi

,

Credentials

PhD, DABCC, NRCC, SC (ASCP)CM

Bio

Dr. Muluhngwi's recent research activities include thestudy of a circulating biomarker for CNS tumors and a retrospective study of oncogenic driver mutations in non-small-cell lung cancer patients. He hopes his interest in HLA and transplantation, which stems from his experience as a laboratory technician, will lead to improving patient care through high-quality laboratory testing and interpretation.

Research Summary

Publications

Sharp C.N., Fletcher A.,Muluhngwi P., Snyder J., Linder M. W., and Jortani S. A.A shared diagnostic stewardship approach toward improving autoimmune encephalopathy send-out testing utilization.  J Appl Lab Med.24 Nov 2020 (https://doi.org/10.1093/jalm/jfaa123)

Muluhngwi P., Valdes, Jr. R., Fernandez-Botran R., Burton E., Williams B., Linder M. W. (2019)Cell-free DNA diagnostics: current and prospective applications in oncology.  Pharmacogenomics. 20(5):357-380.

Muluhngwi P., Sharp C.N., Pozzi N., Elin R., Jortani S. A.Verification of newly FDA- approved kappa and lambda free light chain assays on a previously untested platform.  J Appl Lab Med.2019;4(3):323-330.